EV/EBITDA
-21.12
+0.08+0.38%
1 min ago
Summary
- As of March 12, 2025, AXSM EV/EBITDA is -21.12, with a rise of +0.08 (+0.38%) during the most recent trading day.
- Over the past year, AXSM EV/EBITDA has dropped by -7.38 (-53.71%).
- AXSM EV/EBITDA is now -1524.62% below its all-time high of -1.30.
Performance
AXSM EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
AXSM EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +0.4% | -0.4% | -0.4% |
| 1 m1 month | +9.5% | -9.5% | -9.4% |
| 3 m3 months | -42.1% | +29.7% | +27.7% |
| 6 m6 months | -47.1% | +34.3% | +31.2% |
| ytdytd | - | - | +42.5% |
| 1 y1 year | -53.7% | +86.4% | +73.7% |
| 5 y5 years | +35.7% | +161.4% | +86.1% |
AXSM EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -1.3% | -24.36 | +13.3% | |
| 3 m | 3-month | -13.34 | -58.3% | -24.36 | +13.3% |
| 6 m | 6-month | -13.01 | -62.3% | -24.36 | +13.3% |
| 1 y | 1-year | -10.56 | -100.0% | -24.36 | +13.3% |
| 3 y | 3-year | -6.06 | -248.5% | -27.29 | +22.6% |
| 5 y | 5-year | -6.06 | -248.5% | -39.06 | +45.9% |
| alltime | all time | -1.30 | -1524.6% | -74.77 | +71.8% |
Axsome Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -21.12(+33.0%) |
| 2023 | -15.88(-14.3%) |
| 2022 | -18.52(+64.3%) |
| 2021 | -11.27(-61.2%) |
| 2020 | -29.04(-46.2%) |
| Date | Value |
|---|---|
| 2019 | -53.94(+1966.7%) |
| 2018 | -2.61(-39.4%) |
| 2017 | -4.31(+13.7%) |
| 2016 | -3.79(-66.2%) |
| 2015 | -11.21 |
FAQ
- What is Axsome Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Axsome Therapeutics?
- What is Axsome Therapeutics EV/EBITDA year-on-year change?
What is Axsome Therapeutics EV/EBITDA?
The current EV/EBITDA of AXSM is -21.12
What is the all time high EV/EBITDA for Axsome Therapeutics?
Axsome Therapeutics all-time high EV/EBITDA is -1.30
What is Axsome Therapeutics EV/EBITDA year-on-year change?
Over the past year, AXSM EV/EBITDA has changed by -7.38 (-53.71%)